IQ EQ FUND MANAGEMENT IRELAND Ltd Sells 8,749 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

IQ EQ FUND MANAGEMENT IRELAND Ltd lowered its position in Healthpeak Properties, Inc. (NYSE:DOC) by 12.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 63,980 shares of the real estate investment trust’s stock after selling 8,749 shares during the period. IQ EQ FUND MANAGEMENT IRELAND Ltd’s holdings in Healthpeak Properties were worth $1,297,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in DOC. State Street Corp acquired a new position in shares of Healthpeak Properties during the third quarter worth approximately $1,093,576,000. Geode Capital Management LLC bought a new stake in Healthpeak Properties during the 3rd quarter valued at $403,898,000. Principal Financial Group Inc. raised its holdings in Healthpeak Properties by 2,113.5% during the fourth quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after buying an additional 17,314,572 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in shares of Healthpeak Properties in the third quarter valued at $175,697,000. Finally, JPMorgan Chase & Co. grew its holdings in shares of Healthpeak Properties by 23.2% during the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after buying an additional 4,056,931 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

Shares of DOC opened at $20.24 on Friday. Healthpeak Properties, Inc. has a 1 year low of $17.80 and a 1 year high of $23.26. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The stock’s fifty day moving average price is $20.24 and its two-hundred day moving average price is $21.12. The firm has a market cap of $14.16 billion, a PE ratio of 57.82, a PEG ratio of 2.17 and a beta of 1.14.

Healthpeak Properties Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were issued a dividend of $0.305 per share. The ex-dividend date was Friday, February 14th. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 6.03%. Healthpeak Properties’s dividend payout ratio is 348.57%.

Wall Street Analysts Forecast Growth

DOC has been the topic of a number of analyst reports. Robert W. Baird lowered their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Tuesday, February 11th. Mizuho dropped their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. Wells Fargo & Company cut their target price on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 10th. Wedbush lowered their price target on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, February 14th. Finally, Scotiabank cut their price objective on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a report on Friday, February 28th. Four analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $23.92.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.